6 Best Peptides for Fatty Liver (NAFLD)
Fatty liver disease (NAFLD) has become one of the most actively researched conditions in peptide medicine, and the field spans a wider range of compounds than most people expect, from FDA-approved GLP-1 receptor agonists with biopsy-confirmed human trial data to research peptides whose use is largely community-reported. This guide covers six compounds people actually use or discuss for NAFLD, ordered by how prominently each appears in the research and in real-world use, not as a recommendation of one compound over another. Semaglutide now carries an FDA approval specifically for advanced fatty liver disease, but the entries that follow lay out what each compound is, how it is used for this condition, and where its evidence honestly stands.
